{"id":"https://openalex.org/W4404580893","doi":"https://doi.org/10.1016/j.jlb.2024.100234","title":"A randomized trial of immune checkpoint inhibitor plasma proteomic biomarker and chemotherapy risk model in advanced non-small cell lung cancer","display_name":"A randomized trial of immune checkpoint inhibitor plasma proteomic biomarker and chemotherapy risk model in advanced non-small cell lung cancer","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404580893","doi":"https://doi.org/10.1016/j.jlb.2024.100234"},"language":"en","primary_location":{"id":"doi:10.1016/j.jlb.2024.100234","doi":"https://doi.org/10.1016/j.jlb.2024.100234","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jlb.2024.100234","pdf_url":"https://www.journalofliquidbiopsy.com/article/S2950-1954(24)00100-0/pdf","source":{"id":"https://openalex.org/S4387291454","display_name":"The Journal of Liquid Biopsy","issn_l":"2950-1954","issn":["2950-1954"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Liquid Biopsy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.journalofliquidbiopsy.com/article/S2950-1954(24)00100-0/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008898393","display_name":"Surbhi Singhal","orcid":"https://orcid.org/0000-0003-4307-319X","observed_orcids":["https://orcid.org/0000-0003-4307-319X"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surbhi Singhal","raw_affiliation_strings":["University Of California Davis, Sacramento, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Of California Davis, Sacramento, United States","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080222341","display_name":"Shiruyeh Schokrpur","orcid":"https://orcid.org/0000-0001-9441-9547","observed_orcids":["https://orcid.org/0000-0001-9441-9547"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shiruyeh Schokrpur","raw_affiliation_strings":["University Of California Davis, Sacramento, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Of California Davis, Sacramento, United States","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013360436","display_name":"Yehonatan Elon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yehonatan Elon","raw_affiliation_strings":["OncoHost LTD, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoHost LTD, Israel","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016264665","display_name":"Kimberly McGregor","orcid":"https://orcid.org/0000-0002-9185-5869","observed_orcids":["https://orcid.org/0000-0002-9185-5869"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly McGregor","raw_affiliation_strings":["OncoHost LTD, Cary, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoHost LTD, Cary, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097354090","display_name":"Sharon Ofer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Ofer","raw_affiliation_strings":["OncoHost LTD, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoHost LTD, Israel","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036091074","display_name":"David R. Gandara","orcid":"https://orcid.org/0000-0003-1784-048X","observed_orcids":["https://orcid.org/0000-0003-1784-048X"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Gandara","raw_affiliation_strings":["University Of California Davis, Sacramento, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Of California Davis, Sacramento, United States","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082506495","display_name":"Jonathan Wesley Riess","orcid":"https://orcid.org/0000-0001-7370-7304","observed_orcids":["https://orcid.org/0000-0001-7370-7304"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Riess","raw_affiliation_strings":["University Of California Davis, Sacramento, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Of California Davis, Sacramento, United States","institution_ids":["https://openalex.org/I84218800"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2080,"currency":"USD","value_usd":2080},"apc_paid":{"value":2080,"currency":"USD","value_usd":2080},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.25820201,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":null,"first_page":"100234","last_page":"100234"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.890999972820282},{"id":"https://openalex.org/keywords/plasma-proteomics","display_name":"plasma proteomics","score":0.7630000114440918},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8420000076293945},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9490000009536743},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6899999976158142},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.7277765274047852},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5945947170257568},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5924133062362671},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5465101003646851},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5453859567642212},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4543667137622833},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4378122389316559},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.41119813919067383},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38846805691719055},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37082308530807495},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25505924224853516},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15083777904510498},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jlb.2024.100234","doi":"https://doi.org/10.1016/j.jlb.2024.100234","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jlb.2024.100234","pdf_url":"https://www.journalofliquidbiopsy.com/article/S2950-1954(24)00100-0/pdf","source":{"id":"https://openalex.org/S4387291454","display_name":"The Journal of Liquid Biopsy","issn_l":"2950-1954","issn":["2950-1954"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Liquid Biopsy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jlb.2024.100234","doi":"https://doi.org/10.1016/j.jlb.2024.100234","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jlb.2024.100234","pdf_url":"https://www.journalofliquidbiopsy.com/article/S2950-1954(24)00100-0/pdf","source":{"id":"https://openalex.org/S4387291454","display_name":"The Journal of Liquid Biopsy","issn_l":"2950-1954","issn":["2950-1954"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Liquid Biopsy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404580893.pdf","grobid_xml":"https://content.openalex.org/works/W4404580893.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4379338654","https://openalex.org/W4362593227","https://openalex.org/W4311297297","https://openalex.org/W4412402600","https://openalex.org/W4393092309","https://openalex.org/W4402436619","https://openalex.org/W4416630665","https://openalex.org/W4308399418","https://openalex.org/W3081744155","https://openalex.org/W4399325312"],"abstract_inverted_index":{"Introduction:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"(ICIs)":[4],"that":[5],"target":[6],"PD-(L)1":[7],"have":[8],"significantly":[9],"improved":[10],"outcomes":[11],"in":[12],"non-small":[13],"cell":[14],"lung":[15],"cancer":[16],"(NSCLC).":[17],"However,":[18],"disease":[19],"recurrence":[20],"remains":[21],"common,":[22],"underscoring":[23],"the":[24,60],"limitation":[25],"of":[26,38,55],"current":[27],"FDA-approved":[28],"biomarkers,":[29],"PD-L1":[30],"and":[31],"tumor":[32],"mutational":[33],"burden.":[34],"To":[35],"improve":[36],"prediction":[37],"benefit":[39,64],"from":[40],"ICIs,":[41],"PROphet,":[42],"a":[43,51],"novel":[44],"plasma":[45],"proteomic":[46],"biomarker":[47],"was":[48,68],"developed.":[49],"In":[50],"blinded":[52],"validation":[53],"cohort":[54],"patients":[56],"with":[57,66],"advanced":[58],"NSCLC,":[59],"predicted":[61],"versus":[62],"observed":[63],"rate":[65],"PROphet":[67],"R2=0.98.":[69]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2024-11-22T00:00:00"}